These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33292137)

  • 21. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents.
    Dewaker V; Srivastava AK; Arora A; Prabhakar YS
    J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.
    Moonsamy S; Bhakat S; Ramesh M; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):49-64. PubMed ID: 27981421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target fishing of glycopentalone using integrated inverse docking and reverse pharmacophore mapping approach.
    Gurung AB; Ali MA; Bhattacharjee A; Al-Anazi KM; Farah MA; Al-Hemaid FM; Abou-Tarboush FM; Lee J; Kim SY; Al-Anazi FS
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of Potential IKK-β Inhibitors using Molecular Docking and Molecular Dynamics Techniques for their Anti-cancer Potential.
    Singh SP; Hussain I; Konwar BK; Deka RC; Singh CB
    Curr Comput Aided Drug Des; 2021; 17(1):83-94. PubMed ID: 31899679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches.
    Meganathan C; Sakkiah S; Lee Y; Narayanan JV; Lee KW
    J Mol Model; 2013 Feb; 19(2):715-26. PubMed ID: 23015102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases.
    Broni E; Striegel A; Ashley C; Sakyi PO; Peracha S; Velazquez M; Bebla K; Sodhi M; Kwofie SK; Ademokunwa A; Khan S; Miller WA
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
    Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
    J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling.
    Kumar A; Rai S; Rathi E; Agarwal P; Kini SG
    J Biomol Struct Dyn; 2021 Mar; 39(4):1155-1173. PubMed ID: 32037974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repositioning of experimentally validated anti-breast cancer peptides to target FAK-PAX complex to halt the breast cancer progression: a biomolecular simulation approach.
    Khan A; Shan S; Toor TF; Suleman M; Wang Y; Zhou J; Wei DQ
    Mol Divers; 2023 Apr; 27(2):603-618. PubMed ID: 35635599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
    Mishra A; Rathore AS
    Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.
    Berinyuy E; Soliman MES
    Interdiscip Sci; 2017 Sep; 9(3):406-418. PubMed ID: 27165479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.
    Nikfarjam Z; Bavi O; Amini SK
    Arch Biochem Biophys; 2021 Mar; 699():108747. PubMed ID: 33422503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential inhibitors for LLM of
    Kumari R; Dalal V
    J Biomol Struct Dyn; 2022; 40(20):9833-9847. PubMed ID: 34096457
    [No Abstract]   [Full Text] [Related]  

  • 36. An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer.
    Rajkovic J; Novakovic R; Grujic-Milanovic J; Ydyrys A; Ablaikhanova N; Calina D; Sharifi-Rad J; Al-Omari B
    Front Pharmacol; 2023; 14():1160616. PubMed ID: 37138852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of marine Streptomyces compounds with selected cancer drug target proteins by in silico molecular docking studies.
    Lankapalli AR; Kannabiran K
    Interdiscip Sci; 2013 Mar; 5(1):37-44. PubMed ID: 23605638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
    Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
    J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calotropin and corotoxigenin 3-O-glucopyranoside from the desert milkweed
    Meneses-Sagrero SE; Rascón-Valenzuela LA; García-Ramos JC; Vilegas W; Arvizu-Flores AA; Sotelo-Mundo RR; Robles-Zepeda RE
    PeerJ; 2022; 10():e13524. PubMed ID: 35673388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.